Medicinos partneriai, UAB - financials and debts

Company age: 11 y. 6 mo.

Update

Medicinos partneriai - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 411,510 442,510 470,955 789,978 158,825 557,082 738,940 899,245
Profit before tax 42,917 76,306 441,161 94,143 8,093 -208,551 97,785 20,795
Net profit 36,472 69,084 439,644 80,096 6,879 -208,551 93,331 17,207
Equity 171,283 143,217 135,269 209,469 1,972 -206,578 -113,247 -96,040
Liabilities 171,545 142,233 126,308 198,196 59,695 259,384 157,208 171,060
Non-current assets 197,981 156,436 127,379 131,601 1,053 583 408 3,960
Current assets 143,298 125,664 134,043 275,911 60,614 52,223 43,289 70,907
Total assets 341,279 282,100 261,422 407,512 61,667 52,806 43,697 74,867
Taxes paid
STI taxes - - - - - 21,179 35,976 51,420
Social insurance contributions - - - - - 28,043 47,037 62,734
Financial indicators
Revenue change y/y -3.0% +7.5% +6.4% +67.7% -79.9% +250.8% +32.6% +21.7%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 10.7% 24.5% 168.2% 19.7% 11.2% -394.9% 213.6% 23.0%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 21.3% 48.2% 325.0% 38.2% 348.8% - - -
Profit margin Net profit margin. Shows the overall profitability of the company. 8.9% 15.6% 93.4% 10.1% 4.3% -37.4% 12.6% 1.9%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 10.4% 17.2% 93.7% 11.9% 5.1% -37.4% 13.2% 2.3%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 1.0 1.0 0.9 0.9 30.3 - - -
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 24,206 34,707 43,810 63,198 12,457 53,480 59,512 58,967

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Medicinos partneriai - Social security debts

From To Debt, €
2023-11-16 2023-11-30 4.18
2023-10-27 2023-11-13 4.18
2023-10-17 2023-10-25 4.18
2023-10-09 2023-10-09 4.18
2023-07-26 2023-08-13 0.41
2023-07-24 2023-07-25 0.43
2022-10-18 2022-10-18 2188.20
2022-09-20 2022-10-17 4.70
2022-09-16 2022-09-19 2222.22
2022-07-25 2022-09-15 4.70
2022-07-18 2022-07-19 2292.12
2022-06-20 2022-06-22 48.92
2022-06-16 2022-06-19 2137.82
2022-05-18 2022-06-15 48.92
2022-05-17 2022-05-17 100.24
2022-04-25 2022-05-15 51.32
2022-04-19 2022-04-24 48.92
2022-03-16 2022-03-17 48.92
2022-02-21 2022-02-24 56.96
2022-02-17 2022-02-20 1891.64
2022-01-28 2022-02-16 1.66
2022-01-18 2022-01-19 31.09
2021-12-16 2022-01-16 0.89
2021-11-16 2021-12-14 0.89
2021-10-18 2021-10-18 1384.15

Medicinos partneriai - VMI tax arrears

The company had no tax arrears (debts) to the State Tax Inspectorate

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Medicinos partneriai, UAB (code 303950441) is a Private Limited Liability Company operating in medical specialists activities. In 2025, the company generated EUR 899.2K in revenue and EUR 17.2K in net profit, with a net profit margin of 1.9%. Revenue continued to grow from EUR 557.1K in 2023 to EUR 738.9K in 2024 and EUR 899.2K in 2025, showing a 21.7% year-on-year increase and 61.4% growth over two years. Profitability improved sharply in 2024, when the company reported EUR 93.3K in net profit after a loss of EUR 208.6K in 2023, but earnings eased in 2025. The balance sheet remained tight: total assets were EUR 74.9K at the end of 2025, compared with liabilities of EUR 171.1K and negative equity of EUR 96.0K. Long-term assets were EUR 4.0K and short-term assets EUR 70.9K. Revenue per employee was EUR 60.0K, while profit per employee was EUR 1.1K. Asset turnover was high, reflecting a relatively small asset base.